Evidence map›Paper›PMID 20422015›Full record

ArticlePloS one2010

The peopling of Europe from the mitochondrial haplogroup U5 perspective.

Boris Malyarchuk, Miroslava Derenko, Tomasz Grzybowski, Maria Perkova, Urszula Rogalla, Tomas Vanecek, Iosif Tsybovsky

Abstract readHistorical Article
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Mitogenomics of modern Mongolic-speaking populations.Molecular genetics and genomics : MGG · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Boris MalyarchukInstitute of Biological Problems of the North, Far-East Branch of the Russian Academy of Sciences, Magadan, Russian Federation. malyarchuk@ibpn.ru
Miroslava Derenko
Tomasz Grzybowski
Maria Perkova
Urszula Rogalla
Tomas Vanecek
Iosif Tsybovsky

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is generally accepted that the most ancient European mitochondrial haplogroup, U5, has evolved essentially in Europe. To resolve the phylogeny of this haplogroup, we completely sequenced 113 mitochondrial genomes (79 U5a and 34 U5b) of central and eastern Europeans (Czechs, Slovaks, Poles, Russians and Belorussians), and reconstructed a detailed phylogenetic tree, that incorporates previously published data. Molecular dating suggests that the coalescence time estimate for the U5 is approximately 25-30 thousand years (ky), and approximately 16-20 and approximately 20-24 ky for its subhaplogroups U5a and U5b, respectively. Phylogeographic analysis reveals that expansions of U5 subclusters started earlier in central and southern Europe, than in eastern Europe. In addition, during the Last Glacial Maximum central Europe (probably, the Carpathian Basin) apparently represented the area of intermingling between human flows from refugial zones in the Balkans, the Mediterranean coastline and the Pyrenees. Age estimations amounting for many U5 subclusters in eastern Europeans to approximately 15 ky ago and less are consistent with the view that during the Ice Age eastern Europe was an inhospitable place for modern humans.

Indexed as

Genetics, PopulationPhylogenyPopulation DynamicsClimate ChangeDNA, MitochondrialEuropeGenome, MitochondrialHaplotypesHistoryHistory, AncientHumansDNA, Mitochondrial

Identifiers

PMID20422015
PMCPMC2858207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.